Grantham Mayo Van Otterloo & Co. LLC Has $27.17 Million Stock Holdings in Centene Corporation $CNC

Grantham Mayo Van Otterloo & Co. LLC lifted its stake in Centene Corporation (NYSE:CNC) by 38.0% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 761,490 shares of the company’s stock after purchasing an additional 209,518 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC owned 0.15% of Centene worth $27,170,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CNC. UniSuper Management Pty Ltd increased its position in shares of Centene by 66.0% in the third quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company’s stock worth $3,041,000 after acquiring an additional 33,875 shares in the last quarter. Packer & Co Ltd purchased a new stake in shares of Centene in the 3rd quarter valued at approximately $50,487,000. ARGA Investment Management LP acquired a new position in Centene in the 3rd quarter worth approximately $21,485,000. First Citizens Bank & Trust Co. grew its position in Centene by 122.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company’s stock worth $7,962,000 after purchasing an additional 122,870 shares in the last quarter. Finally, Amundi grew its position in Centene by 6.2% during the 2nd quarter. Amundi now owns 3,384,752 shares of the company’s stock worth $183,724,000 after purchasing an additional 199,016 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Price Performance

Shares of CNC opened at $43.70 on Monday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. The firm has a market cap of $21.49 billion, a PE ratio of -3.21, a PEG ratio of 0.97 and a beta of 0.48. The firm’s 50 day moving average price is $43.25 and its 200 day moving average price is $38.18. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03.

Centene (NYSE:CNC) last posted its earnings results on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. The company had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The company’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CNC has been the subject of a number of research analyst reports. Truist Financial increased their target price on Centene from $47.00 to $49.00 and gave the company a “buy” rating in a report on Wednesday, February 25th. JPMorgan Chase & Co. upped their price target on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft increased their price objective on Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research note on Tuesday, February 10th. TD Cowen lifted their target price on Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday, February 11th. Finally, Jefferies Financial Group dropped their target price on Centene from $43.00 to $37.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Centene presently has a consensus rating of “Hold” and a consensus target price of $42.44.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.